TZcheck CA19-9 Rapid Test
CA19-9 Rapid Test
|
Cat. No. |
T005-4002 |
|
Product Description |
CA19-9 Rapid Test |
|
Specimen |
WB/S/P |
|
Format |
Cassette |
|
Kit Size |
10 T |
|
Cut-Off |
40 U/mL |
|
Status |
CE |
CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis(a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer. CA19-9 is an antigen defined by monoclonal antibody binding to CA19-9, the tumor surface marker Sialyl-Lewis A. CA19-9 was discovered in the serum of patients with colon cancer and pancreatic cancer in 1981. The main use of CA19-9 is to see whether a pancreatic tumor is secreting it; if that is the case, then the levels should fall when the tumor is treated, and they may rise again if the disease recurs. In people with pancreatic masses, CA19-9 can be useful in distinguishing between cancer and other diseases of the gland. Because of its rising and falling levels with treatment, CA 19-9 is used as a prognostic marker for pancreatic cancer.
